These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 29158834)
1. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy. Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834 [TBL] [Abstract][Full Text] [Related]
2. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses. Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885 [TBL] [Abstract][Full Text] [Related]
4. Antigen-loaded polymeric hybrid micelles elicit strong mucosal and systemic immune responses after intranasal administration. Li Y; Li M; Gong T; Zhang Z; Sun X J Control Release; 2017 Sep; 262():151-158. PubMed ID: 28756271 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant. Jérôme V; Graser A; Müller R; Kontermann RE; Konur A J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372 [TBL] [Abstract][Full Text] [Related]
6. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide. Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352 [TBL] [Abstract][Full Text] [Related]
7. Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines. Zeng Q; Li H; Jiang H; Yu J; Wang Y; Ke H; Gong T; Zhang Z; Sun X Biomaterials; 2017 Apr; 122():105-113. PubMed ID: 28110170 [TBL] [Abstract][Full Text] [Related]
8. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes. Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549 [TBL] [Abstract][Full Text] [Related]
9. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol). Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134 [TBL] [Abstract][Full Text] [Related]
10. Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs. Kapadia CH; Tian S; Perry JL; Luft JC; DeSimone JM Mol Pharm; 2016 Oct; 13(10):3381-3394. PubMed ID: 27551741 [TBL] [Abstract][Full Text] [Related]
11. The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin. Shi S; Shi K; Tan L; Qu Y; Shen G; Chu B; Zhang S; Su X; Li X; Wei Y; Qian Z Biomaterials; 2014 May; 35(15):4536-47. PubMed ID: 24582554 [TBL] [Abstract][Full Text] [Related]
12. Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy. Su Q; Wang C; Song H; Zhang C; Liu J; Huang P; Zhang Y; Zhang J; Wang W J Mater Chem B; 2021 May; 9(18):3892-3899. PubMed ID: 33928989 [TBL] [Abstract][Full Text] [Related]
13. Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma. Zhuang X; Wu T; Zhao Y; Hu X; Bao Y; Guo Y; Song Q; Li G; Tan S; Zhang Z J Control Release; 2016 Apr; 228():26-37. PubMed ID: 26921522 [TBL] [Abstract][Full Text] [Related]
14. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs. Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685 [TBL] [Abstract][Full Text] [Related]
15. Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma. Mu LM; Liu L; Liu R; Du YF; Luo Q; Xu JR; Xie Y; Lu WL Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060324 [TBL] [Abstract][Full Text] [Related]
16. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems. Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124 [TBL] [Abstract][Full Text] [Related]
17. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy. Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105 [TBL] [Abstract][Full Text] [Related]
18. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response. Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509 [TBL] [Abstract][Full Text] [Related]
19. Extending antigen release from particulate vaccines results in enhanced antitumor immune response. Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma. Zhu M; Ding X; Zhao R; Liu X; Shen H; Cai C; Ferrari M; Wang HY; Wang RF J Control Release; 2018 Feb; 272():72-82. PubMed ID: 29325699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]